Acrolein Human Health Risk Assessment; Notice of Availability

Riepilogo

This notice announces the availability of EPA's human health risk assessment, and related documents for the pesticide acrolein, and opens a public comment period on these documents (Phase 3 of 6-Phase Process). The public is encouraged to suggest risk management ideas or proposals to address the risks identified. EPA is developing a Reregistration Eligibility Decision (RED) for acrolein through a 6- Phase public participation process that the Agency uses to involve the public in developing pesticide reregistration decisions. Through this process, EPA is ensuring that all pesticides meet current health and safety standards.